BIG
UTHR icon

Brooklyn Investment Group’s United Therapeutics UTHR Stock Holding History

Brooklyn Investment Group’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.21M Buy
3,728
+935
+33% +$466K 0.07% 255
2025
Q4 		$1.4M Buy
+2,793
New +$1.3M 0.06% 245
2025
Q3 		– Sell
-578
Closed -$166K – 2588
2025
Q2 		$166K Buy
578
+385
+199% +$115K 0.02% 698
2025
Q1 		$59.5K Buy
193
+98
+103% +$33.6K 0.01% 715
2024
Q4 		$33.5K Buy
95
+2
+2% +$735 0.01% 626
2024
Q3 		$33.3K Buy
+93
New +$31.4K 0.01% 562

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Brooklyn Investment Group's UTHR Position: Q1 2026 in Review

Brooklyn Investment Group increased its United Therapeutics (UTHR) stake by 33% in Q1 2026, buying an estimated $466K and bringing the position to 3,728 shares worth $2.21M. The position accounts for 0.07% of the portfolio, ranked #255.

Brooklyn Investment Group first reported a position in UTHR in Q3 2024 and has held it in 6 quarters since. 854 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.

  • Brooklyn Investment Group held 3,728 shares of United Therapeutics worth $2.21M as of Q1 2026.
  • Brooklyn Investment Group bought 935 United Therapeutics shares in Q1 2026, an estimated $466K.
  • United Therapeutics made up 0.07% of Brooklyn Investment Group's portfolio in Q1 2026, its #255 holding.
  • Brooklyn Investment Group first reported a position in United Therapeutics in Q3 2024 and has held it in 6 quarters since.
  • 854 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.

Based on Brooklyn Investment Group's 13F filing for Q1 2026, filed 29 Apr 2026.